Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
- 16 April 2007
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 18 (6) , 559-563
- https://doi.org/10.1097/wnr.0b013e3280b07c21
Abstract
Aggregation of the amyloid-β (Aβ) peptide into amyloid plaques is a characteristic feature of Alzheimer's disease neuropathogenesis. We and others have previously demonstrated delayed Aβ aggregation as a consequence of oxidizing a single methionine residue at position 35 (Met-35). Here, we examined the consequences of Met-35 oxidation on the extremely aggregation-prone peptides Aβ1-42 and Aβ1-40Arctic with respect to protofibril and oligomer formation as well as neurotoxicity. Size exclusion chromatography and mass spectrometry demonstrated that monomer/dimers prevailed over larger oligomers after oxidizing Met-35, and consequently protofibril formation and aggregation of both Aβ1-42 and Aβ1-40Arctic were delayed. The oxidized peptides completely lacked neurotoxic effects in cortical neuronal cultures under these conditions, in contrast to the neurotoxic properties of the unoxidized peptides. We conclude that oxidation of Met-35 significantly attenuates aggregation of Aβ1-42 and Aβ1-40Arctic, and thereby reduces neurotoxicity.Keywords
This publication has 18 references indexed in Scilit:
- Alzheimer’s amyloid β-peptide (1–42) induces cell death in human neuroblastoma via bax/bcl-2 ratio increase: An intriguing role for methionine 35Biochemical and Biophysical Research Communications, 2006
- The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicityBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2005
- Methionine 35 Oxidation Reduces Fibril Assembly of the Amyloid Aβ-(1–42) Peptide of Alzheimer's DiseaseJournal of Biological Chemistry, 2002
- Oxidation of Methionine 35 Attenuates Formation of Amyloid β-Peptide 1–40 OligomersJournal of Biological Chemistry, 2002
- ADDLs & protofibrils —the missing links?Neurobiology of Aging, 2002
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Protofibrillar Intermediates of Amyloid β-Protein Induce Acute Electrophysiological Changes and Progressive Neurotoxicity in Cortical NeuronsJournal of Neuroscience, 1999
- Amyloid β-Protein FibrillogenesisJournal of Biological Chemistry, 1999
- Solution Structure of Methionine-Oxidized Amyloid β-Peptide (1−40). Does Oxidation Affect Conformational Switching?,Biochemistry, 1998
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991